Cargando…
Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
Cisplatin resistance is one of the main causes of chemotherapy failure and tumor progression in non-small cell lung cancer (NSCLC). Emodin has been demonstrated to induce NSCLC cell apoptosis and act as a potential cancer therapeutic agent. However, whether emodin could affect NSCLC cell sensitivity...
Autores principales: | Peng, Shuai, Wang, Jincheng, Lu, Chang, Xu, Zelin, Chai, Jing-Jing, Ke, Qing, Deng, Xin-Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856686/ https://www.ncbi.nlm.nih.gov/pubmed/33613719 http://dx.doi.org/10.3892/ol.2021.12491 |
Ejemplares similares
-
Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation
por: Li, Xinxing, et al.
Publicado: (2016) -
MICA enhances sensitivity to cisplatin in patients with extensive small cell lung cancer via downregulation of ABCG2
por: Wu, Yufeng, et al.
Publicado: (2020) -
N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD
por: O'Reilly, Philip, et al.
Publicado: (2009) -
Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation
por: Ma, Jun, et al.
Publicado: (2014) -
PGP: Pretty Good Privacy
por: Garfinkel, Simson
Publicado: (1995)